X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with GSK Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs GSK PHARMA - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD GSK PHARMA MERCK LTD/
GSK PHARMA
 
P/E (TTM) x 33.6 63.8 52.6% View Chart
P/BV x 3.8 10.3 36.6% View Chart
Dividend Yield % 0.8 1.2 61.0%  

Financials

 MERCK LTD   GSK PHARMA
EQUITY SHARE DATA
    MERCK LTD
Dec-16
GSK PHARMA
Mar-17
MERCK LTD/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0603,838 27.6%   
Low Rs6232,637 23.6%   
Sales per share (Unadj.) Rs632.4354.2 178.6%  
Earnings per share (Unadj.) Rs45.739.8 115.0%  
Cash flow per share (Unadj.) Rs62.342.9 145.4%  
Dividends per share (Unadj.) Rs11.0030.00 36.7%  
Dividend yield (eoy) %1.30.9 141.1%  
Book value per share (Unadj.) Rs388.8236.9 164.1%  
Shares outstanding (eoy) m16.6084.70 19.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.39.1 14.6%   
Avg P/E ratio x18.481.4 22.6%  
P/CF ratio (eoy) x13.575.5 17.9%  
Price / Book Value ratio x2.213.7 15.8%  
Dividend payout %24.175.4 31.9%   
Avg Mkt Cap Rs m13,969274,216 5.1%   
No. of employees `0001.64.7 33.7%   
Total wages/salary Rs m1,4874,830 30.8%   
Avg. sales/employee Rs Th6,631.96,387.0 103.8%   
Avg. wages/employee Rs Th939.21,028.3 91.3%   
Avg. net profit/employee Rs Th479.4717.1 66.9%   
INCOME DATA
Net Sales Rs m10,49830,000 35.0%  
Other income Rs m242728 33.3%   
Total revenues Rs m10,74130,728 35.0%   
Gross profit Rs m1,1354,190 27.1%  
Depreciation Rs m276263 104.8%   
Interest Rs m00-   
Profit before tax Rs m1,1024,655 23.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0457 0.0%   
Tax Rs m3431,744 19.7%   
Profit after tax Rs m7593,368 22.5%  
Gross profit margin %10.814.0 77.4%  
Effective tax rate %31.137.5 83.1%   
Net profit margin %7.211.2 64.4%  
BALANCE SHEET DATA
Current assets Rs m6,41016,742 38.3%   
Current liabilities Rs m8,8287,202 122.6%   
Net working cap to sales %-23.031.8 -72.5%  
Current ratio x0.72.3 31.2%  
Inventory Days Days5852 111.3%  
Debtors Days Days3821 184.7%  
Net fixed assets Rs m1,4068,635 16.3%   
Share capital Rs m166847 19.6%   
"Free" reserves Rs m6,28619,222 32.7%   
Net worth Rs m6,45520,069 32.2%   
Long term debt Rs m010 0.0%   
Total assets Rs m8,82830,038 29.4%  
Interest coverage xNMNM-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.21.0 119.1%   
Return on assets %8.611.2 76.7%  
Return on equity %11.816.8 70.1%  
Return on capital %17.125.5 67.1%  
Exports to sales %8.30-   
Imports to sales %21.00-   
Exports (fob) Rs m869NA-   
Imports (cif) Rs m2,209NA-   
Fx inflow Rs m959528 181.6%   
Fx outflow Rs m2,6127,193 36.3%   
Net fx Rs m-1,653-6,665 24.8%   
CASH FLOW
From Operations Rs m1,0702,360 45.4%  
From Investments Rs m-7503,008 -24.9%  
From Financial Activity Rs m-150-5,108 2.9%  
Net Cashflow Rs m171260 65.7%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.8 50.7 102.2%  
Indian inst/Mut Fund % 18.2 10.2 178.4%  
FIIs % 1.0 23.8 4.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 15.4 189.0%  
Shareholders   28,591 102,036 28.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   AUROBINDO PHARMA  DR. REDDYS LAB  ABBOTT INDIA  FULFORD INDIA  ORCHID PHARMA LTD  

Compare MERCK LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Marginally Higher; IT Stocks Witness Buying Interest(11:30 am)

Stock markets in India are presently trading marginally higher. Sectoral indices are trading on a mixed note with stocks in the IT sector and consumer durables sector witnessing maximum buying interest.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Feb 20, 2018 12:03 PM

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD - ORCHID PHARMA LTD COMPARISON

COMPARE MERCK LTD WITH

MARKET STATS